Clinical Trial Update: Safety and Efficacy of Mirazid for Schistosomiasis Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Mirazid for schistosomiasis has completed, reporting safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• Mirazid

Snippet

Sponsor: Pharco Pharmaceuticals | Conditions: Schistosoma Hematobium Infection, Schistosomiasis Mansoni | Phase 3 | Status: COMPLETED